# FDA Inspection 1121347 - Astex Pharmaceuticals, Inc - February 24, 2020

Source: https://www.keypedia.com/records/fda_inspections/astex-pharmaceuticals-inc/b817f1bd-c76e-4fc2-9580-8ed2109d82b8
Source feed: FDA_Inspections

> FDA Inspection 1121347 for Astex Pharmaceuticals, Inc on February 24, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121347
- Company Name: Astex Pharmaceuticals, Inc
- Inspection Date: 2020-02-24
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 770888 - 2012-03-06](https://www.keypedia.com/records/fda_inspections/astex-pharmaceuticals-inc/92dc646a-d9eb-48ec-be45-8306114d5f82)

Company: https://www.keypedia.com/companies/astex-pharmaceuticals-inc/c20ffb61-868e-417e-aa16-740aed045c07

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
